The Cannabis ETF (THCX) Stock Analysis

The Cannabis ETF (THCX) Financial Services Profile

The Cannabis ETF (THCX) provides investors exposure to the cannabis industry through a rules-based index of cannabis companies' exchange-listed common stock and ADRs, operating as a non-diversified fund within the asset management sector, targeting a minimum of 80% investment in cannabis-related securities.

What Is the Investment Thesis for THCX?

The Cannabis ETF (THCX) presents a focused investment opportunity within the cannabis industry. Its primary value driver is the performance of its underlying index, which tracks a portfolio of cannabis companies. A key growth catalyst is the expanding legalization and acceptance of cannabis globally, potentially increasing the profitability and market value of cannabis businesses. However, the non-diversified nature of the fund introduces potential risks, as its performance is heavily reliant on the cannabis sector's overall health and regulatory landscape. With a beta of 1.60, THCX exhibits higher volatility compared to the broader market, requiring investors to carefully consider their risk tolerance. As of 2026-03-18, the fund has a market cap of $12.9M.

Based on FMP financials and quantitative analysis

THCX Key Highlights

THCX is a non-diversified fund, concentrating its investments in cannabis companies.

• The fund invests at least 80% of its assets in the component securities of its proprietary index.
• THCX focuses on exchange-listed common stock and ADRs of cannabis companies, ensuring liquidity.
• The fund's beta of 1.60 indicates higher volatility compared to the overall market.
• As of 2026-03-18, THCX has a market capitalization of $12.9M.

Who Are THCX's Competitors?

THCX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are THCX's Key Strengths?

Focused exposure to the cannabis industry.

• Rules-based index provides transparency.
• Investments in exchange-listed securities and ADRs ensure liquidity.
• Established brand presence in the cannabis investment space.

What Are THCX's Weaknesses?

Non-diversified nature increases risk.

• High beta indicates higher volatility.
• Performance heavily reliant on the cannabis sector's overall health.
• Regulatory uncertainty in the cannabis industry.

What Could Drive THCX Stock Higher?

THCX catalyst: Potential changes in cannabis legalization policies in key markets could drive investor sentiment and increase valuations.

• Continued product innovation and market expansion by cannabis companies within the fund's portfolio.
• Increased institutional investment in the cannabis sector, leading to higher demand for THCX shares.

What Are the Key Risks for THCX?

Regulatory setbacks or changes in cannabis policies could negatively impact the industry and the fund's performance.

• Market volatility and fluctuations in cannabis stock prices could lead to losses for investors.
• Competition from other cannabis ETFs and investment vehicles could erode THCX's market share.
• Negative public perception of the cannabis industry could affect investor sentiment.

What Are the Growth Opportunities for THCX?

• Expansion of Legalization: The ongoing trend of cannabis legalization across various jurisdictions represents a significant growth opportunity for THCX. As more countries and states legalize cannabis for medical or recreational use, the market size for cannabis companies is expected to increase substantially. This expansion could lead to higher revenues and profits for cannabis businesses, driving up their stock prices and benefiting THCX's portfolio. The timeline for this growth is dependent on legislative and regulatory developments, but the overall trend suggests continued expansion in the coming years.
• Product Innovation and Diversification: Cannabis companies are increasingly focusing on product innovation and diversification to cater to evolving consumer preferences. This includes the development of new cannabis-infused products, such as edibles, beverages, and topicals, as well as the exploration of different cannabinoid formulations. As cannabis companies expand their product offerings and target new market segments, they have the potential to increase their revenue streams and attract a broader customer base. This innovation-driven growth could positively impact the performance of THCX's holdings.
• Mergers and Acquisitions: The cannabis industry is witnessing a wave of mergers and acquisitions (M&A) as companies seek to consolidate their market positions and achieve economies of scale. These M&A activities can create larger, more competitive cannabis companies with stronger financial profiles and broader geographic reach. As cannabis companies combine their resources and expertise, they may be able to accelerate their growth and improve their profitability, benefiting THCX's investment portfolio. The pace of M&A activity in the cannabis industry is expected to remain robust in the near term.
• Increased Institutional Investment: As the cannabis industry matures and gains greater legitimacy, institutional investors are becoming more willing to allocate capital to cannabis-related assets. This increased institutional investment can provide a significant boost to the valuations of cannabis companies, as well as improve their access to capital for expansion and innovation. As more institutional investors enter the cannabis market, THCX could benefit from increased demand for its shares and higher valuations for its underlying holdings.
• Global Market Expansion: While the cannabis industry is currently concentrated in North America, there is significant potential for global market expansion. As more countries around the world legalize cannabis for medical or recreational use, cannabis companies have the opportunity to enter new markets and tap into new customer bases. This global expansion could drive significant revenue growth for cannabis companies and increase their overall market value, benefiting THCX's investment portfolio. The timeline for global market expansion will vary depending on regulatory developments in different countries.

What Are THCX's Competitive Advantages?

• Proprietary Index: The fund's rules-based index provides a unique and transparent approach to investing in cannabis companies.
• Focused Exposure: THCX offers targeted exposure to the cannabis sector, which may be attractive to investors seeking specific industry exposure.
• Liquidity: The fund's focus on exchange-listed securities and ADRs ensures liquidity for investors.
• Brand Recognition: THCX has established a brand presence in the cannabis investment space.

What Does THCX Do?

The Cannabis ETF (THCX) is designed to provide investors with exposure to the cannabis industry through a focused investment strategy. The fund operates by investing at least 80% of its total assets in the component securities of its proprietary index, which is meticulously crafted using a rules-based approach. This index is designed to track the performance of a portfolio consisting of Cannabis Companies. Furthermore, under normal market conditions, THCX allocates a minimum of 80% of its net assets, supplemented by borrowings for investment purposes, into exchange-listed common stock or corresponding American Depositary Receipts (ADRs) of Cannabis Companies. As a non-diversified fund, THCX concentrates its investments in a smaller number of holdings compared to diversified funds. This approach can potentially lead to higher volatility but also offers the possibility of greater returns if the cannabis sector performs well. The fund's investment strategy is centered around capturing the growth and performance of companies operating within the cannabis industry, making it a targeted investment vehicle for those seeking exposure to this specific market segment. THCX's investment objective is to closely replicate the performance of its underlying index, providing investors with a transparent and rules-based approach to investing in cannabis-related equities. The fund's focus on exchange-listed securities and ADRs ensures liquidity and accessibility for investors.

What Products and Services Does THCX Offer?

• Invests in a portfolio of cannabis companies.
• Tracks the performance of a proprietary, rules-based index.
• Allocates at least 80% of total assets to component securities of the index.
• Focuses on exchange-listed common stock and ADRs of cannabis companies.
• Operates as a non-diversified fund.
• Provides investors with exposure to the cannabis industry.

How Does THCX Make Money?

• Generates revenue through investment returns from its portfolio of cannabis companies.
• Manages assets based on a rules-based index tracking cannabis companies.
• Attracts investors seeking exposure to the cannabis market.
• Rebalances its portfolio to maintain alignment with the underlying index.

What Industry Does THCX Operate In?

The Cannabis ETF (THCX) operates within the asset management industry, specifically targeting the cannabis sector. The cannabis market is experiencing growth driven by increasing legalization and acceptance worldwide. This growth presents opportunities for companies involved in cannabis cultivation, processing, distribution, and retail. However, the industry also faces regulatory hurdles and competitive pressures. THCX competes with other ETFs and investment vehicles that offer exposure to the cannabis market, such as DYLS, FLHK, GSFP, GULF, and HLGE. The fund's success depends on its ability to accurately track its underlying index and attract investors seeking targeted exposure to the cannabis sector.

Who Are THCX's Key Customers?

• Retail investors seeking exposure to the cannabis industry.
• Institutional investors looking for targeted cannabis investments.
• Financial advisors seeking cannabis-related investment products for their clients.
• Investors with a high-risk tolerance due to the volatility of the cannabis market.

THCX Valuation & Market Position

With a $12.9M market cap, The Cannabis ETF sits in the micro-cap segment of the market.

Return on equity for The Cannabis ETF stands at 0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. THCX trades at a trailing price-to-earnings ratio of 0.00, below the Financial Services sector average of ~18x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.

THCX Financials

THCX Latest News

No recent news available for THCX.

What Investors Ask About The Cannabis ETF (THCX) — Financial Services

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources